Determining the Risks of Magnetic Resonance Imaging at 1.5 Tesla for Patients With Pacemakers and Implantable Cardioverter Defibrillators

Dec 7, 2016 by in CARDIOLOGY Comments Off on Determining the Risks of Magnetic Resonance Imaging at 1.5 Tesla for Patients With Pacemakers and Implantable Cardioverter Defibrillators

Conventional pacemaker and implantable cardioverter-defibrillator product labeling currently cautions against exposure to magnetic resonance imaging (MRI). However, there is a growing clinical need for MRI, without an acceptable alternative imaging…

read more

Multi-Ethnic Study of Atherosclerosis Arterial Age Versus Framingham 10-Year or Lifetime Cardiovascular Risk

Dec 7, 2016 by in CARDIOLOGY Comments Off on Multi-Ethnic Study of Atherosclerosis Arterial Age Versus Framingham 10-Year or Lifetime Cardiovascular Risk

Methods to improve coronary heart disease (CHD) risk prediction include incorporation of coronary artery calcium (CAC) within risk models and considering longer time horizons such as evaluation of lifetime cardiovascular…

read more

Capecitabine -Induced Chest Pain Relieved by Diltiazem

Dec 7, 2016 by in CARDIOLOGY Comments Off on Capecitabine -Induced Chest Pain Relieved by Diltiazem

Five patients with primary colorectal adenocarcinoma or anal squamous cell carcinoma were started on a 2-weeks-on, 1-week-off capecitabine dosing regimen in addition to other chemotherapeutic agents and/or radiation. Within the…

read more

Effect of Gender, Caregiver, on Cholesterol Control and Statin Use for Secondary Prevention Among Hospitalized Patients With Coronary Heart Disease

Dec 7, 2016 by in CARDIOLOGY Comments Off on Effect of Gender, Caregiver, on Cholesterol Control and Statin Use for Secondary Prevention Among Hospitalized Patients With Coronary Heart Disease

Women with coronary heart disease (CHD) are consistently less likely than men with CHD to be at low-density lipoprotein (LDL) cholesterol goals, and the reasons for the gender gap are…

read more

Bleeding Complications With Regional Adaptation of a Prolonged Bivalirudin Regimen for ST-Elevation Acute Myocardial Infarction

Dec 7, 2016 by in CARDIOLOGY Comments Off on Bleeding Complications With Regional Adaptation of a Prolonged Bivalirudin Regimen for ST-Elevation Acute Myocardial Infarction

Bivalirudin (BIV) is superior to a heparin/glycoprotein IIb/IIIa receptor inhibitor (GPI) strategy with respect to net adverse cardiovascular events for ST-segment elevation myocardial infarction (STEMI) percutaneous coronary intervention (PCI), albeit…

read more

Comparison of Outcomes in Patients With Versus Without Diabetes Mellitus After Revascularization With Everolimus – and Sirolimus -Eluting Stents (from the SORT OUT IV Trial)

Dec 7, 2016 by in CARDIOLOGY Comments Off on Comparison of Outcomes in Patients With Versus Without Diabetes Mellitus After Revascularization With Everolimus – and Sirolimus -Eluting Stents (from the SORT OUT IV Trial)

Diabetes is associated with increased risk of major adverse cardiac events (MACEs) after percutaneous coronary intervention. The purpose of this substudy of the SORT OUT IV trial was to compare…

read more

Impact of Clopidogrel Loading Dose in Patients With Chronic Kidney Disease Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Dec 7, 2016 by in CARDIOLOGY Comments Off on Impact of Clopidogrel Loading Dose in Patients With Chronic Kidney Disease Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

The optimal loading dose of clopidogrel in patients with chronic kidney disease who undergo primary percutaneous coronary intervention for ST-segment elevation myocardial infarction has not been investigated. The aim of…

read more
Get Clinical Tree app for offline access